ClinVar Miner

Submissions for variant NM_000152.5(GAA):c.1129G>C (p.Gly377Arg)

gnomAD frequency: 0.00003  dbSNP: rs752002666
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000592368 SCV000701129 pathogenic not provided 2017-04-03 criteria provided, single submitter clinical testing
Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard RCV001249091 SCV001423072 likely pathogenic Glycogen storage disease, type II 2020-01-22 criteria provided, single submitter curation The heterozygous p.Gly377Arg variant in GAA has been reported in 1 individual with Glycogen Storage Disease II (PMID: 16860134), and has also been reported pathogenic by EGL Genetic Diagnostics in ClinVar (Variation ID: 497033). This variant has been identified in 0.002% (3/127352) of European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs752002666). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. In vitro functional studies provide some evidence that the p.Gly377Arg variant may impact GAA protein levels and activity (PMID: 18425781). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in combination with a pathogenic variant and in an individual with Glycogen Storage Disease II increases the likelihood that the p.Gly377Arg variant is pathogenic (PMID: 16860134). The phenotype of an individual heterozygous for this variant is highly specific for Glycogen Storage Disease II based on very low GAA activity compared to normal, consistent with disease (PMID: 16860134). In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic. ACMG/AMP Criteria applied: PS3, PM2, PP3, PP4, PM3_Supporting (Richards 2015).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.